US vaccination patent approved

BioArctic s US patent on an Alzheimer vaccine was approved today. BioArctic Neuroscience AB has a proprietary technological platform for immunotherapy against misfolded proteins.

Alzheimer´s disease is the most common dementia disorder and currently there are no effective treatments that can stop the disease progress.